B-cell lymphomas are characterized by somatic hypermutation (SHM) events in immunoglobulin genes that lead to abnormal SHM; IGV SHM may enhance the B-cell receptor (BCR) affinity and B-cell survival, suggesting unfavorable prognostic effects [33]. Here, BCR is linked to B-cell non-Hodgkin lymphoma.